Erratum: Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. (Diabetes Care, 2022, 45, 2189–2201)

Randy L. Anderson; Linda A. Dimeglio; Adrian P. Mander; Colin M. Dayan; Peter S. Linsley; Kevan C. Herold; Marjana Marinac; Simi T. Ahmed

doi:10.2337/dc22-er12a

Erratum: Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. (Diabetes Care, 2022, 45, 2189–2201)

Randy L. Anderson
, Linda A. Dimeglio
, Adrian P. Mander
, Colin M. Dayan
, Peter S. Linsley
, Kevan C. Herold
, Marjana Marinac
, Simi T. Ahmed

Immunology and Immunotherapy

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Original language	English
Pages (from-to)	3113-3113
Number of pages	1
Journal	Diabetes Care
Volume	45
Issue number	12
Early online date	11 Oct 2022
DOIs	https://doi.org/10.2337/dc22-er12a
Publication status	Published - Dec 2022

Bibliographical note

Erratum to: Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189–2201

Publisher Copyright:
© American Diabetes Association Inc.

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialised Nursing

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dc22-er12a

1 Article

Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
Anderson, R. L., Dimeglio, L. A., Mander, A. P., Dayan, C. M., Linsley, P. S., Herold, K. C., Marinac, M. & Ahmed, S. T., Oct 2022, In: Diabetes Care. 45, 10, p. 2189-2201 13 p.
Research output: Contribution to journal › Article › peer-review

Cite this

Anderson, R. L., Dimeglio, L. A., Mander, A. P., Dayan, C. M., Linsley, P. S., Herold, K. C., Marinac, M., & Ahmed, S. T. (2022). Erratum: Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. (Diabetes Care, 2022, 45, 2189–2201). Diabetes Care, 45(12), 3113-3113. https://doi.org/10.2337/dc22-er12a

@article{3cb3b80b8b164351be9d4f7df690f7e9,

title = "Erratum: Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. (Diabetes Care, 2022, 45, 2189–2201)",

author = "Anderson, \{Randy L.\} and Dimeglio, \{Linda A.\} and Mander, \{Adrian P.\} and Dayan, \{Colin M.\} and Linsley, \{Peter S.\} and Herold, \{Kevan C.\} and Marjana Marinac and Ahmed, \{Simi T.\}",

note = "Erratum to: Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189–2201 Publisher Copyright: {\textcopyright} American Diabetes Association Inc.",

year = "2022",

month = dec,

doi = "10.2337/dc22-er12a",

language = "English",

volume = "45",

pages = "3113--3113",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association",

number = "12",

}

Anderson, RL, Dimeglio, LA, Mander, AP, Dayan, CM, Linsley, PS, Herold, KC, Marinac, M & Ahmed, ST 2022, 'Erratum: Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. (Diabetes Care, 2022, 45, 2189–2201)', Diabetes Care, vol. 45, no. 12, pp. 3113-3113. https://doi.org/10.2337/dc22-er12a

Erratum: Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. (Diabetes Care, 2022, 45, 2189–2201). / Anderson, Randy L.; Dimeglio, Linda A.; Mander, Adrian P. et al.
In: Diabetes Care, Vol. 45, No. 12, 12.2022, p. 3113-3113.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Erratum

T2 - Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. (Diabetes Care, 2022, 45, 2189–2201)

AU - Anderson, Randy L.

AU - Dimeglio, Linda A.

AU - Mander, Adrian P.

AU - Dayan, Colin M.

AU - Linsley, Peter S.

AU - Herold, Kevan C.

AU - Marinac, Marjana

AU - Ahmed, Simi T.

N1 - Erratum to: Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189–2201 Publisher Copyright: © American Diabetes Association Inc.

PY - 2022/12

Y1 - 2022/12

UR - https://www.scopus.com/pages/publications/85143201540

U2 - 10.2337/dc22-er12a

DO - 10.2337/dc22-er12a

M3 - Comment/debate

C2 - 36219765

AN - SCOPUS:85143201540

SN - 0149-5992

VL - 45

SP - 3113

EP - 3113

JO - Diabetes Care

JF - Diabetes Care

IS - 12

ER -

Erratum: Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. (Diabetes Care, 2022, 45, 2189–2201)

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Fingerprint

Research output

Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes

Cite this